New diabetes clinical trial: Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)

Published on: May 07, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Ustekinumab;   Drug: Placebo
Sponsors:   University of British Columbia;   Juvenile Diabetes Research Foundation;   Janssen, LP
Not yet recruiting